Bone drugs may have addedbenefit: Lower pneumonia risk

By Nicholas Bakalar

Osteoporosis drugs such as Fosamax and Actonel may have an additional benefit: A new study suggests they are associated with a reduced risk for pneumonia.

Researchers studied the nitrogen-containing bisphosphonates, prescription drugs sold under various brand names for the treatment of osteoporosis. Using a database of patients 50 and older hospitalized for hip fracture, the scientists compared 4,041 people who used bisphosphonates with 11,802 who were not exposed to the drugs.

Read more about this article in our issue today...

3 views0 comments